Intensive Models of HCV Care for Injection Drug Users Read more about Intensive Models of HCV Care for Injection Drug Users
Impact of Hidradenitis Suppurativa on Quality of Life Functions Read more about Impact of Hidradenitis Suppurativa on Quality of Life Functions
A National Registry For Patients With Hidradenitis Suppurativa Read more about A National Registry For Patients With Hidradenitis Suppurativa
A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children Read more about A Study of Nevirapine Used Alone or in Combination With AZT in HIV-1-Infected Children
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Read more about Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY)
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Read more about Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions Read more about Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Read more about Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations Read more about Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma Read more about Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma